About PCAI
PCAI is a company based in Toronto (Canada) founded in 2020 by Tyler Burpee was acquired by Osoyoos Cannabis in June 2020. PCAI operates in a competitive market with competitors including ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.
- Headquarter Toronto, Canada
- Founders Tyler Burpee
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Osoyoos Cannabis
(Jun 29, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PCAI
Detailed funding history for PCAI
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in PCAI
PCAI has secured backing from 1 investor. Prominent investors backing the company include Osoyoos Cannabis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cannabis extraction, processing, and licensing services are provided.
|
Locked | Locked | Locked |
Investor details for PCAI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PCAI
Investment portfolio details for PCAI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PCAI
Detailed financials for PCAI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pcai Comparisons
Peer comparison for PCAI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PCAI
PCAI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cannabis-derived therapeutics for multiple indications are developed.
|
|
| Locked | Locked | Locked |
Developer of cannabinoid-based pharmaceuticals and well-being products
|
|
| Locked | Locked | Locked |
Medical cannabis products are provided based on GMP processes.
|
|
| Locked | Locked | Locked |
Plant-derived cannabinoid products are developed for medical and consumer uses.
|
|
| Locked | Locked | Locked |
Manufacturer of medicinal cannabis for therapeutic use
|
|
| Locked | Locked | Locked |
Developer of medical cannabis products
|
Detailed competitors of PCAI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pcai
Complete news archive for PCAI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PCAI
PCAI was founded in 2020.
PCAI is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
PCAI was founded in 2020 in Toronto, Canada, within the cannabis and biotechnology sector. Artificial intelligence is applied to create plant-based and fungal-based medicines, including pharmaceutical, nutraceutical, and cosmeceutical items derived from cannabis and psilocybin. Operations focus on treatments for conditions such as anxiety, ADHD, ulcerative colitis, Crohns disease, cancers, addictions, Alzheimers, depression, PTSD, Parkinsons, and related disorders.
PCAI's top competitors include Avicanna, ZYUS Life Sciences and Neocannbio.
PCAI has 1 investor. Key investors include Osoyoos Cannabis.